Moderna, REV Group, Rocket Pharmaceuticals And Other Big Stocks Moving Higher On Wednesday
Portfolio Pulse from Lisa Levin
Several US stocks recorded gains in Wednesday's session. Rocket Pharmaceuticals shares climbed 31.8% after reaching alignment with the FDA on a global Phase 2 trial. ECARX Holdings, VEON Ltd., and HireRight Holdings also saw significant gains. REV Group reported better-than-expected Q3 results and raised FY23 net sales guidance, leading to a 9.2% gain. Moderna surged 5.6% after announcing business and clinical updates and long term guidance.
September 13, 2023 | 2:14 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Moderna surged 5.6% after announcing business and clinical updates and long term guidance.
The announcement of business and clinical updates and long term guidance are positive developments for Moderna, likely to boost investor confidence and drive the stock price up in the short term.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100
POSITIVE IMPACT
Rocket Pharmaceuticals shares climbed 31.8% after reaching alignment with the FDA on a global Phase 2 trial.
The alignment with the FDA on a global Phase 2 trial is a significant positive development for Rocket Pharmaceuticals, which is likely to boost investor confidence and drive the stock price up in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100
POSITIVE IMPACT
REV Group reported better-than-expected Q3 results and raised FY23 net sales guidance, leading to a 9.2% gain.
Better-than-expected Q3 results and raised FY23 net sales guidance are strong positive signals for REV Group, likely to increase investor confidence and push the stock price up in the short term.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100